News
Does BioNTech SE Sponsored ADR (BNTX) have what it takes to be a top stock pick for momentum investors? Let's find out.
Market Catalysts host Julie Hyman tracks today's top moving stocks and biggest market stories in this Market Minute. Arm ...
7d
Zacks.com on MSNHas BioNTech (BNTX) Outpaced Other Medical Stocks This Year?
Here is how BioNTech SE Sponsored ADR (BNTX) and EUROFINS SCIENT (ERFSF) have performed compared to their sector so far this year.
3d
Zacks.com on MSNShould You Buy, Hold, or Sell BMY Stock Ahead of Q2 Earnings?
Detailed price information for Biontech Se ADR (BNTX-Q) from The Globe and Mail including charting and trades.
One relatively safe bet about how Pfizer's lineup will look different five years from now is that the company will be a ...
Detailed price information for Biontech Se ADR (BNTX-Q) from The Globe and Mail including charting and trades.
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, July 29th: GDS Holdings Limited GDS: This data center operator from China has a Zacks Rank #1 ...
10h
Zacks Investment Research on MSNBristol Myers Beats on Q2 Earnings and Sales, Raises '25 Sales View
Bristol-Myers Squibb Company (BMY) reported second-quarter 2025 adjusted earnings per share (EPS) of $1.46, which comfortably ...
The race to develop effective cancer vaccines has entered a new phase, with late-stage trials from companies like Moderna ...
Pfizer Inc. (NYSE: PFE, "Pfizer") and BioNTech SE (Nasdaq: BNTX, "BioNTech") announced today that the European Medicines Agency's (EMA) Committee for ...
The 12-month price targets, analyzed by analysts, offer insights with an average target of $133.42, a high estimate of $155.00, and a low estimate of $110.00. A negative shift in sentiment is evident ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results